Literature DB >> 36149529

Distress response in granulosa cells of women affected by PCOS with or without insulin resistance.

Mauro Cozzolino1,2,3,4, Sonia Herraiz5, Yigit Cakiroglu6,7, Juan Antonio Garcia-Velasco8,9, Bulent Tiras6,7, Alberto Pacheco9, Susana Rabadan9, Graciela Kohls9, Ana Isabel Barrio9, Antonio Pellicer10,5, Emre Seli11,12.   

Abstract

PURPOSE: In this study, we investigated whether metabolic dysfunction in women with Polycystic ovarian syndrome (PCOS) induces granulosa cell (GC) stress and activates in the endoplamatic reticulum and the mitochondria (UPRer and UPRmt, respectively).
METHODS: Women who were diagnosed with PCOS (based on the Rotterdam criteria), were divided into two groups, PCOS with insulin resistance (PCOS-IR; n = 20) and PCOS with no insulin resistance (PCOS-nIR; n = 20), and compared to healthy oocyte donors (CONT; n = 20). Insulin resistance (IR) was assessed on the results of homeostasis model assessment (HOMA) that determines IR using the concentration of fasting plasma glucose and fasting insuline. Expression of UPRer genes (i.e., IRE1, ATF4, ATF6, XBP1, BIP, and CHOP), and UPRmt genes (i.e., HSP60, HSP10, CLPP, and HSP40) was assessed in cumulus GCs by qRT-PCR.
RESULTS: We found that several genes involved in UPRer and UPRmt were overexpressed in the GCs of PCOS-IR and PCOS-nIR compared to CONT. IRE1, ATF4 and XBP1, that are activated by ER stress, were significantly overexpressed in PCOS-IR compared to CONT. BIP and CHOP were overexpressed in PCOS groups compared to CONT. HSP10 and HSP40 were upregulated in PCOS-IR and PCOS-nIR groups compared to the CONT. HSP60 and CLPP showed no statistical different expression in PCOS-IR and PCOS-nIR compared to CONT group.
CONCLUSION: Our findings suggest that the GCs of women with PCOS (with or without IR) are metabolically distressed and upregulate UPRer and UPRmt genes. Our study contributes to the understanding of the molecular mechanisms underlying the pathological changes that occur in the follicular microenvironment of women with PCOS.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Endoplasmic reticulum; Hyperinsulinemia; Metabolic distress; Mitochondria; PCOS; Unfolded protein response

Year:  2022        PMID: 36149529     DOI: 10.1007/s12020-022-03192-8

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.925


  43 in total

1.  Obesity and Polycystic Ovary Syndrome.

Authors:  Susan Sam
Journal:  Obes Manag       Date:  2007-04

2.  PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.

Authors:  F J Broekmans; E A H Knauff; O Valkenburg; J S Laven; M J Eijkemans; B C J M Fauser
Journal:  BJOG       Date:  2006-10       Impact factor: 6.531

3.  Oxidative status in granulosa cells of infertile women undergoing IVF.

Authors:  Narendra Babu Karuputhula; Ratna Chattopadhyay; Baidyanath Chakravarty; Koel Chaudhury
Journal:  Syst Biol Reprod Med       Date:  2013-01-02       Impact factor: 3.061

Review 4.  Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Sharon E Oberfield; Elisabet Stener-Victorin; John C Marshall; Joop S Laven; Richard S Legro
Journal:  Endocr Rev       Date:  2015-10       Impact factor: 19.871

5.  Differential expression of inflammation-related genes in the ovarian stroma and granulosa cells of PCOS women.

Authors:  Johanna Schmidt; Birgitta Weijdegård; Anne Lis Mikkelsen; Svend Lindenberg; Lars Nilsson; Mats Brännström
Journal:  Mol Hum Reprod       Date:  2013-07-29       Impact factor: 4.025

Review 6.  Mitochondrial function in women with polycystic ovary syndrome.

Authors:  Mauro Cozzolino; Emre Seli
Journal:  Curr Opin Obstet Gynecol       Date:  2020-06       Impact factor: 1.927

Review 7.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Héctor F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  Fertil Steril       Date:  2008-10-23       Impact factor: 7.329

8.  Impact of obesity on the risk for polycystic ovary syndrome.

Authors:  Bulent O Yildiz; Eric S Knochenhauer; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2007-10-09       Impact factor: 5.958

9.  Enhanced Inflammatory Transcriptome in the Granulosa Cells of Women With Polycystic Ovarian Syndrome.

Authors:  Jaye Adams; Zhilin Liu; Yi Athena Ren; Wan-Song Wun; Wei Zhou; Shlomit Kenigsberg; Clifford Librach; Cecilia Valdes; William Gibbons; JoAnne Richards
Journal:  J Clin Endocrinol Metab       Date:  2016-05-26       Impact factor: 5.958

Review 10.  Therapy with probiotics and synbiotics for polycystic ovarian syndrome: a systematic review and meta-analysis.

Authors:  Mauro Cozzolino; Amerigo Vitagliano; Livia Pellegrini; Martina Chiurazzi; Alessandra Andriasani; Guido Ambrosini; Nicolas Garrido
Journal:  Eur J Nutr       Date:  2020-05-05       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.